Prioritize a protein region for functional testing.
Position can support transcript crosswalking, recurrence review, construct design, and region-aware functional testing.
VARIANT LANDSCAPE
Read the connected-person position map, then distinguish exact recurrence from unrelated molecular situations.
OBSERVED COUNTS BY PROTEIN INTERVAL
Each cell shows the number of people with a result in that interval. Color intensity uses one scale within each figure. Neither bands nor color establish mutation rate, enrichment, hotspots, severity, or prognosis.
Scroll horizontally to review every protein interval.
| Molecular class | 1–500 | 501–1,000 | 1,001–1,500 | 1,501–2,000 | 2,001–2,500 | 2,501–2,964 |
|---|---|---|---|---|---|---|
| Predicted truncating | 1 | 6 | 12 | 6 | 8 | 1 |
| Missense | 5 | 7 | 3 | 1 | 1 | 2 |
| All people shown | 6 | 13 | 15 | 7 | 9 | 3 |
Position can support transcript crosswalking, recurrence review, construct design, and region-aware functional testing.
Class and interval do not establish RNA fate, protein abundance, mechanism, phenotype attribution, treatment response, or prognosis.
RECURRENCE, RELATEDNESS & ADDITIONAL FINDINGS
The current group includes 1 related-family cluster, 3 complex/mixed/in-frame results (two complex/mixed and one in-frame deletion), and 22 of 65 people with an additional finding recorded, including reported or unresolved findings.
Scroll horizontally to review every column.
| Structure | Count and unit | What it can show | What it does not show |
|---|---|---|---|
| Familial structure | 5 related people in 1 family | Study segregation, penetrance, and within-family variability. | 5 related people do not represent 5 independent recurrence events. |
| Complex / mixed / in-frame architecture | 3 people: 2 complex/mixed + 1 in-frame deletion | Distinguish multiple ASH1L events from a simple in-frame deletion; assess phase and any additional finding separately. | These results do not form one molecular subtype. |
| Additional findings | 22 / 65 people with an additional finding recorded | Includes reported or unresolved genetic and clinical findings, VUS and carrier findings, each considered separately. Updated September 24, 2026. | This counts people, not confirmed additional diagnoses, causal explanations, or additional ASH1L cases. |
EXACT RECURRENCE
An exact allele match requires the same ASH1L change, written against the same reference, in unrelated families. A shared residue, codon, consequence, or interval alone is not counted as the same allele.